These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Monoclonal antibody therapy of malignant melanoma: in vivo localization in cutaneous metastasis after intravenous administration. Oldham RK; Foon KA; Morgan AC; Woodhouse CS; Schroff RW; Abrams PG; Fer M; Schoenberger CS; Farrell M; Kimball E J Clin Oncol; 1984 Nov; 2(11):1235-44. PubMed ID: 6333489 [TBL] [Abstract][Full Text] [Related]
8. Imaging of melanoma with L-131-labeled monoclonal antibodies. Larson SM; Brown JP; Wright PW; Carrasquillo JA; Hellström I; Hellström KE J Nucl Med; 1983 Feb; 24(2):123-9. PubMed ID: 6822875 [TBL] [Abstract][Full Text] [Related]
9. [Initial experiences with a new monoclonal antibody in diagnosis of malignant melanomas]. Omlor G; Berberich R; Gross G; Alexander C; Feifel G Langenbecks Arch Chir; 1991; 376(6):359-62. PubMed ID: 1775002 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of metastatic melanoma with planar and SPECT scintigraphy using ZME 018 and 96.5 radiolabeled monoclonal antibodies. Jaffe RM; Alderson PO; Seldin DW; Esser PD; Bartholomew RM; Hyman GA Cancer Detect Prev; 1988; 12(1-6):303-12. PubMed ID: 3263197 [TBL] [Abstract][Full Text] [Related]
11. Immunoscintigraphy with 99mTc labelled F(ab')2 fragments of an anti melanoma monoclonal antibody (225.28S) in patients with metastatic malignant melanoma. Cerny T; Owens SE; Mackenzie SA; Nuttall PM; Gosh AK; Smith DB; Thatcher N Eur J Nucl Med; 1987; 13(3):130-3. PubMed ID: 3622556 [TBL] [Abstract][Full Text] [Related]
12. Clinical use of a standard kit-preparation of radiolabeled monoclonal antibody 96.5 in the diagnostic imaging of metastatic melanoma. Saleh MN; Miller DM; Peterson L; Russell CD; Unger MW; Urist MM; Wheeler RH; LoBuglio AF J Clin Oncol; 1988 Jun; 6(6):1059-65. PubMed ID: 3373261 [TBL] [Abstract][Full Text] [Related]
13. [Immunoscintigraphy with 99mTc marked melanoma antibody in patients with malignant melanoma]. Rentsch M; Cerny T; Richner J; Brunner KW; Rösler H; Nachbur B Helv Chir Acta; 1989 Jun; 56(1-2):11-3. PubMed ID: 2777587 [TBL] [Abstract][Full Text] [Related]
14. A technetium-labeled monoclonal antibody for imaging metastatic melanoma. Frytak S; Creagan ET; Brown ML; Salk D; Nelp W Am J Clin Oncol; 1991 Apr; 14(2):156-61. PubMed ID: 2028923 [TBL] [Abstract][Full Text] [Related]
15. [Clinical application of monoclonal antibodies to human malignant melanoma-associated antigens]. Kageshita T; Ishihara K Gan To Kagaku Ryoho; 1985 Sep; 12(9):1744-8. PubMed ID: 3899015 [TBL] [Abstract][Full Text] [Related]
16. [Immunoscintigraphy with a technetium 99m-labeled monoclonal antibody in patients with melanoma]. Dudczak R; Kletter K; Bailer H; Kokoschka E; Pohl-Markl H Wien Klin Wochenschr; 1987 Apr; 99(7):232-9. PubMed ID: 3590802 [TBL] [Abstract][Full Text] [Related]
17. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions. Serban ED; Farnetani F; Pellacani G; Constantin MM Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304 [TBL] [Abstract][Full Text] [Related]
18. Unmasking of a primary desmoplastic melanoma tumour in the course of treatment of a metastatic disease with anti-PD-1 monoclonal antibody. Richtig G; Ramelyte E; Koch L; Greinix H; Ferrone S; Dummer R; Richtig E J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):e381-e383. PubMed ID: 31081948 [No Abstract] [Full Text] [Related]